Articles From: Meridian Bioscience Reports Third Quarter and Nine Months Operating Results, Declares Regular Cash Dividend, and Reaffirms Fiscal 2014 Guidance to Imprimis Pharmaceuticals' Go Dropless™ Cataract Surgery Formulations to be Featured in Two Sessions at the 2014 American-European Congress of Ophthalmic Surgery (AECOS) Summer Symposium


Meridian Bioscience, Inc. (NASDAQ: VIVO) today: reported fiscal 2014 third quarter and first nine months net sales of $47.2 million and $142.1 million, respectively, flat and an increase of 2%, respectively, from the same periods of the prior fiscal year; reported third quarter operating income of $13.1 million, a decrease of 16% from the same period of the prior fiscal year; reported nine months operating income of $40.4 million, a decrease of 8% from the same period of the prior fiscal year; reported third quarter net earnings of $8.8 million, or $0.21 per diluted share, decreases of 13% compared to the fiscal 2013 third quarter; reported first nine months net earnings of $26.6 million, or $0.63 per diluted share, decreases of 8% and 9%, respectively, compared to the
Sign-up for Meridian Bioscience Reports Third Quarter and Nine Months Operating Results, Declares Regular Cash Dividend, and Reaffirms Fiscal 2014 Guidance investment picks
YuMe, Inc. (NYSE: YUME), a leading provider of digital video brand advertising solutions, today announced that it will release second quarter 2014 financial results after the market closes on Wednesday, August 13.
Sign-up for YuMe to Report Second Quarter Financial Results on August 13 investment picks
HAMPTON, Va., July 24, 2014 (GLOBE NEWSWIRE) -- Measurement Specialties, Inc. (Nasdaq:MEAS) , (the "Company"), a global designer and manufacturer of sensors and sensor-based systems, held the grand opening of their new West China R&D and Manufacturing Center in Chengdu today.
Sign-up for Measurement Specialties Opens New Greenfield Facility in Chengdu investment picks
Dover Downs Gaming & Entertainment, Inc. (NYSE: DDE) today reported results for the three months ended June 30, 2014.
Sign-up for Dover Downs Gaming & Entertainment, Inc. Reports Results for the Second Quarter Ended June 30, 2014 investment picks
Dover Motorsports, Inc. (NYSE: DVD) today reported results for the three months ended June 30, 2014.
Sign-up for Dover Motorsports, Inc. Reports Results for the Second Quarter of 2014 investment picks
2014/7/24
ATLANTA , July 24, 2014 /PRNewswire/ -- Gray Television, Inc. ("Gray" or "we" or "our") (NYSE: GTN and GTN.A) announced today that it has agreed to acquire WJRT-TV and WTVG-TV from affiliates of SJL Holdings, LLC ("SJL") for approximately $128.0 million in cash.
Sign-up for Gray To Acquire ABC Affiliate In Flint, Michigan, And ABC/CW Affiliate In Toledo, Ohio From SJL Holdings investment picks
8x8, Inc. (NASDAQ:EGHT), a provider of cloud-based unified communications, contact center and collaboration solutions, today announced the availability of a new, out-of-the-box integration with Zendesk’s customer service platform that enhances the Customer Experience Management capabilities of the 8x8 Virtual Office cloud telephony and unified communications (UC) platform.
Sign-up for 8x8 Extends Partnership With Zendesk to Enhance Customer Experience Management With the Virtual Office Cloud Telephony Platform investment picks
2014/7/24
Active International Equity Specialist with Close to US$10 billion in AUM BALTIMORE , July 24, 2014 /PRNewswire/ -- Legg Mason (NYSE:LM) today announced the acquisition of Martin Currie, an active international equity specialist based in the United Kingdom.
Sign-up for Legg Mason Announces Acquisition Of Martin Currie investment picks
NEW YORK (MarketWatch) -- Valeant Pharmaceuticals International Inc. (VRX) said Thursday it has filed an official and detailed complaint with the Canadian regulator, Autorite des Marches Financiers, about statements made by Allergan Inc. (AGN) regarding Valeant's business.
Sign-up for Valeant files official complaint about Allergan with Canadian regulator investment picks
PETALUMA, Calif., July 24, 2014 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (Nasdaq:OCLS) , today announced that the financial results for its fiscal first quarter 2015, ended June 30, 2014, will be released after the U.S. markets close on August 7, 2014.
Sign-up for Oculus Innovative Sciences Announces Fiscal First Quarter 2015 Financial Results and Conference Call investment picks
Materion Corporation (NYSE:MTRN) today reported second quarter financial results.
Sign-up for Materion Corporation Reports Second Quarter Financial Results Revises Full-Year Guidance investment picks
- Patent will protect MYOS' intellectual property portfolio for Fortetropin through 2033 – CEDAR KNOLLS, N.J., July 24, 2014 (GLOBE NEWSWIRE) -- MYOS Corporation ("MYOS" or the "Company") (Nasdaq:MYOS) , an emerging biotherapeutics and bionutrition company focused on the discovery, development and commercialization of products that improve muscle health and performance, announced today that it recently received a Notice of Allowance from the U.S. Patent and Trademark Office ("USPTO") for U.S. Patent Application Serial No.
Sign-up for MYOS Corporation Receives Notice of Allowance of U.S. Patent Application for Proprietary Manufacturing Methods of Fortetropin investment picks
2014/7/24
Argent Energy Trust announces higher than expected second quarter production and provides operational update Canada NewsWire Note regarding barrel of oil equivalency Barrels of oil equivalent (boe) may be misleading, particularly if used in isolation.
Sign-up for Argent Energy Trust announces higher than expected second quarter production and provides operational update investment picks
Esperion Therapeutics, Inc. (Nasdaq: ESPR), a clinical-stage biopharmaceutical company focused on developing and commercializing first-in-class, oral, low-density lipoprotein cholesterol (LDL-cholesterol) lowering therapies for the treatment of patients with hypercholesterolemia and other cardiometabolic risk markers, today announced dosing of the first patient in its Phase 2 clinical study of ETC-1002 in patients with hypercholesterolemia and hypertension, ETC-1002-014.
Sign-up for Esperion Therapeutics Announces Initiation of a Phase 2 Clinical Study of ETC-1002 in Patients with Hypercholesterolemia and Hypertension investment picks
ATLANTA , July 24, 2014 /PRNewswire/ -- Second Quarter and Recent Highlights: Appointed Pat Mackin as President and Chief Executive Officer effective September 2, 2014 Product revenues grew 12 percent year-over-year to $20.4 million BioGlue ® revenues grew 14 percent year-over-year to $15.3 million PerClot ® revenues grew 22 percent year-over-year to $1.1 million HeRO ® Graft revenues grew 20 percent year-over-year to $1.7 million Tissue processing revenues decreased 6 percent year-over-year to $14.3 million CryoLife, Inc. (NYSE: CRY) , a leading medical device and tissue processing company focused on cardiac and vascular surgery, announced today its results for the second quarter and first six months of 2014.
Sign-up for CryoLife Second Quarter 2014 Revenues Increase 3 Percent to a Record $34.7 Million investment picks
2014/7/24
By MarketWatch 3M profit, sales rise in line with forecasts 3M(MMM)reported second-quarter net profit of $1.27 billion, or $1.91 a share, up from $1.2 billion, or $1.71 a share, a year ago.
Sign-up for Updates, advisories and surprises investment picks
The Board of Directors of Crestwood Equity GP LLC, general partner of Crestwood Equity Partners LP (NYSE:CEQP) (“Crestwood Equity”) announced that it has declared the partnership’s quarterly cash distribution of $0.1375 per limited partner unit ($0.55 annually) for the quarter ended June 30, 2014.
Sign-up for Crestwood Equity Partners Announces Quarterly Distribution and Conference Call Schedule investment picks
Connection to HIE will enable the exchange and use of critical patient data to improve outcomes CHICAGO and LITTLE ROCK, Ark.
Sign-up for Allscripts Connects to State of Arkansas HIE investment picks
GREENVILLE, S.C. , July 24, 2014 /PRNewswire/ -- KEMET Corporation (the "Company") (NYSE: KEM) , a leading global supplier of electronic components, today reported preliminary results for our first quarter ended June 30, 2014.
Sign-up for KEMET Reports Preliminary Fiscal 2015 First Quarter Results investment picks
Motorola Solutions Inc. (NYSE:MSI) is unveiling a new wireless local area network (WLAN) offering that is easy to manage and deploy without sacrificing best-in-class technology.
Sign-up for Motorola Solutions Unveils WiNG Express, Offering Small and Mid-size Businesses a High-performance Enterprise-class WLAN investment picks
Valeant Pharmaceuticals Files An Official Complaint With The Autorite Des Marches Financiers About Allergan's False And Misleading Statements Canada NewsWire LAVAL, Quebec , July 24, 2014 /CNW/ -- Valeant Pharmaceuticals International, Inc. ("Valeant") (NYSE:VRX) (TSX:VRX) announced today that it has filed a detailed complaint with the Autorite des marches financiers ("AMF") regarding Allergan, Inc.'s (NYSE: AGN) apparent attempts to mislead investors and to negatively influence the market price of Valeant's common shares by continuing to make false and misleading statements regarding Valeant's business despite Valeant's public statements correcting this misinformation.
Sign-up for Valeant Pharmaceuticals Files An Official Complaint With The Autorite Des Marches Financiers About Allergan's False And Misleading Statements investment picks
LAVAL, Quebec , July 24, 2014 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. ("Valeant") (NYSE:VRX) (TSX:VRX) announced today that it has filed a detailed complaint with the Autorite des marches financiers ("AMF") regarding Allergan, Inc.'s (NYSE: AGN) apparent attempts to mislead investors and to negatively influence the market price of Valeant's common shares by continuing to make false and misleading statements regarding Valeant's business despite Valeant's public statements correcting this misinformation.
Sign-up for Valeant Pharmaceuticals Files An Official Complaint With The Autorite Des Marches Financiers About Allergan's False And Misleading Statements investment picks
Beacon Roofing Supply, Inc. (NASDAQ: BECN) (the "Company") will host a webcast and conference call on Friday August 8, 2014 at 10:00 a.m. ET to discuss its earnings results for the third quarter ended June 30, 2014.
Sign-up for Beacon Roofing Supply to Announce Third Quarter 2014 Earnings on August 8, 2014 investment picks
Cabela's Incorporated (NYSE:CAB) today reported financial results for second quarter fiscal 2014.
Sign-up for Cabela's Inc. Posts Strong Second Quarter 2014 EPS and Profitability investment picks
Sales Reach unites the power of Salesforce1 Sales Cloud, Pardot and Communities into a new solution that empowers sales reps to connect with customers in entirely new ways With on-the-spot marketing and selling tools, sales reps will now be able to deploy 1:1 campaigns tailored to prospects' actions to advance buyers through the sales process--all from their mobile device Salesforce1 Sales Cloud, the world's #1 sales app, accelerates the sales of leading companies such as Borrego Solar, Newell Rubbermaid and Precor SAN FRANCISCO , July 24, 2014 /PRNewswire/ -- Salesforce.com (NYSE: CRM) , the world's #1 CRM platform, today unveiled Salesforce1 Sales Reach—now sales reps can accelerate sales with a new solution for instant marketing and selling.
Sign-up for Salesforce.com Unveils Salesforce1 Sales Reach--Now Sales Reps Can Accelerate Sales with a New Solution for Instant Marketing and Selling investment picks
RTI Surgical Inc. (RTI) (Nasdaq: RTIX), a global surgical implant company, reported operating results for the second quarter of 2014 as follows: Quarterly Highlights: Achieved revenues of $66 million, exceeding revenue guidance of $62 to $63 million.
Sign-up for RTI Surgical™ Announces 2014 Second Quarter Results investment picks
2014/7/24
PRINCETON JUNCTION, N.J., July 24, 2014 (GLOBE NEWSWIRE) -- MISTRAS Group, Inc. (NYSE:MG) announced the award of a multi-year contract to provide Fleet Radiography services to Southern Nuclear, the nuclear energy operating subsidiary of Southern Company (NYSE:SO) .
Sign-up for MISTRAS Group Awarded Fleet-Wide Contract by Southern Nuclear for Radiography Services investment picks
- Imprimis' proprietary ophthalmic compounded formulations now available by prescription in 32 states and territories - SAN DIEGO , July 24, 2014 /PRNewswire/ -- Imprimis Pharmaceuticals, Inc. (Nasdaq: IMMY) , a vertically-integrated specialty pharmaceutical company focused on the development and commercialization of proprietary sterile and topical compounded drug formulations, announced today that two Key Opinion Leader (KOL) presentations that describe the benefits of dropless cataract surgery formulations will be delivered at the upcoming American-European Congress of Ophthalmic Surgery (AECOS) Summer Symposium in Deer Valley, Utah from July 24 – 27, 2014.
Sign-up for Imprimis Pharmaceuticals' Go Dropless™ Cataract Surgery Formulations to be Featured in Two Sessions at the 2014 American-European Congress of Ophthalmic Surgery (AECOS) Summer Symposium investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Meridian Bioscience Reports Third Quarter and Nine Months Operating Results, Declares Regular Cash Dividend, and Reaffirms Fiscal 2014 Guidance to Imprimis Pharmaceuticals' Go Dropless™ Cataract Surgery Formulations to be Featured in Two Sessions at the 2014 American-European Congress of Ophthalmic Surgery (AECOS) Summer Symposium
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices